NBIX — Neurocrine Biosciences Inc
In 2026 Q2, 5 of the 140 tracked hedge funds reported a position in Neurocrine Biosciences Inc (NBIX), worth $436.55M combined. Over the quarter 2 opened or added, 5 trimmed or exited.
Hedge fund holders, 2026 Q2
| Fund | Value | Portfolio % | Change |
|---|---|---|---|
| Renaissance | $393.68M | 0.54% | -3.4% |
| PKO | $28.79M | 8.20% | +23.1% |
| VanEck | $11.71M | 0.00% | -22% |
| Quadrature | $2.30M | 0.02% | -0.1% |
| Persistent | $74.16K | 0.02% | NEW |
All stocks · Quarterly Trends · Hedge Fund Tracker
Source: SEC EDGAR 13F filings, reported as of quarter end and filed up to 45 days later. Not investment advice.